Laurion Capital Management LP - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 2 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$126,076
-69.3%
11,287
+38.0%
0.00%
-80.0%
Q2 2020$411,000
+9.0%
8,178
+34.1%
0.01%
+66.7%
Q4 2019$377,0006,1000.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 936,777$53,218,00016.69%
Fairmount Funds Management LLC 316,952$18,006,0006.55%
ARMISTICE CAPITAL, LLC 1,836,000$104,303,0001.77%
Soleus Capital Management, L.P. 182,400$10,362,0001.62%
Portland Global Advisors LLC 62,635$3,558,0000.66%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 40,000$2,263,0000.55%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$113,336,0000.53%
Yorktown Management & Research Co Inc 10,400$591,0000.44%
Hennion & Walsh Asset Management, Inc. 120,240$6,831,0000.36%
Virtus ETF Advisers LLC 9,599$545,0000.24%
View complete list of ENANTA PHARMACEUTICALS INC shareholders